ChloroPlant Secures Major Green Hydrogen Plant Contract in Sarawak, Malaysia

ChloroPlant Secures Major Green Hydrogen Plant Contract in Sarawak, Malaysia

SEOUL, South Korea, March 27, 2025 /PRNewswire/ -- Chloroplant Co. Ltd., a member of the Marcon LC group of companies specializing in systems integration and project management in the alternative energy sector, announced today it has secured a...

TOYO Co., Ltd Announces Plans for Additional 2GW Solar Cell Capacity Expansion in Ethiopia

TOYO Co., Ltd Announces Plans for Additional 2GW Solar Cell Capacity Expansion in Ethiopia

TOKYO, March 26, 2025 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO) (OTC: TOYWF) ("TOYO" or the "Company"), a solar solution company, is excited to announce it will begin building an additional 2 gigawatts (GW) expansion of its solar cell capacity at...

ANNOUNCEMENT OF ANNUAL RESULTS FOR 2024

ANNOUNCEMENT OF ANNUAL RESULTS FOR 2024

Notable Progress in R&D and Commercialization Gross Profit Surging 68% FINANCIAL HIGHLIGHTS • Revenue was approximately RMB1,933.0 million, representing a year-on-year increase of 25.5%. • Gross profit was approximately RMB1,273.7 million,...

TOKYO GAS Co., Ltd.: Action Policy Toward Continuous Corporate Value Enhancement

TOKYO GAS Co., Ltd.: Action Policy Toward Continuous Corporate Value Enhancement

TOKYO, March 26, 2025 /PRNewswire/ -- FY25 marks our 140th anniversary and the final year of our current Medium-Term Management Plan (MTMP). As we reach this milestone, we are reaffirming our commitment to continuous corporate value enhancement....

Kelun-Biotech's Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors

Kelun-Biotech's Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors

CHENGDU, China, March 26, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the investigational new drug application for a...

HMS for Car Builds In-Vehicle Ecosystem with Southeast Asian Partners

HMS for Car Builds In-Vehicle Ecosystem with Southeast Asian Partners

BANGKOK, March 25, 2025 /PRNewswire/ -- Huawei's HMS for Car showcased innovations at the Bangkok International Motor Show, highlighting upgrades to its MAAN3.0 architecture (MAP BOX, AI BOX, APP BOX, NET BOX) and localized collaborations to advance...

LightInTheBox Reports Fourth Quarter and Full Year 2024 Financial Results

LightInTheBox Reports Fourth Quarter and Full Year 2024 Financial Results

SINGAPORE, March 25, 2025 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global specialty retailer focusing on proprietary apparel brands and design-driven collections tailored to evolving consumer...

ANO-NE Kids Club to Open in Ginza, Japan on April 1: Safe "Playcation" for Kids, Carefree Time for Parents

ANO-NE Kids Club to Open in Ginza, Japan on April 1: Safe "Playcation" for Kids, Carefree Time for Parents

TOKYO, March 25, 2025 /PRNewswire/ -- ANO-NE Kids Club, an innovative indoor play facility providing short-term childcare, will open in Tokyo's Ginza district on April 1, 2025. Developed by Cosmos Hotel Management Co., Ltd. and COSMOS INITIA Co.,...

FOR SALE BY EXPRESSION OF INTEREST: FREEHOLD CONSERVATION SHOPHOUSE WITH RARE F&B APPROVAL AT 350/350A TANJONG KATONG ROAD

FOR SALE BY EXPRESSION OF INTEREST: FREEHOLD CONSERVATION SHOPHOUSE WITH RARE F&B APPROVAL AT 350/350A TANJONG KATONG ROAD

SINGAPORE, March 25, 2025 /PRNewswire/ -- Brilliance Capital Pte. Ltd. is pleased to present an exceptional opportunity to acquire a freehold conservation two-storey shophouse with an attic at 350/350A Tanjong Katong Road. This rare offering is...

Sungen Biomedical's world-first new drug SGC001 monoclonal antibody receives FDA fast track approval

Sungen Biomedical's world-first new drug SGC001 monoclonal antibody receives FDA fast track approval

NEW YORK, March 24, 2025 /PRNewswire/ -- On March 17, 2025, US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical—an innovative biopharmaceutical company incubated by Beijing Hotgen...

  • 1
  • ...
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • ...
  • 46
  • menu
    menu